en · de · es · fr · pt
thymosin-alpha-1-notes.peptides5388.com › Info › Storage Stability And Analytical Testing — Reference Sheet

Storage Stability And Analytical Testing — Reference Sheet

By Editorial Desk · published 2026-05-31 · last reviewed 2026-07-08 · Info

Everything below concerns solid-phase synthesis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-07-08. Numbers and descriptions here follow the published literature rather than marketing material.

Storage Stability and Analytical Testing

Lyophilized thymosin alpha-1 is generally stored at or below minus twenty degrees Celsius, protected from moisture and light. Short-term handling at ambient temperature is possible for dry powder, but reconstituted solutions degrade faster and are usually kept at two to eight degrees Celsius with a defined expiry of days rather than weeks. Repeated freeze-thaw cycles should be avoided because they promote aggregation and loss of potency. Exact limits depend on the formulation and should follow the supplier's documentation.

Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.

Molecular Structure and Biological Background

Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.

Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.

Thymosin-alpha-1 at a glance

PropertyValueNotes
Storage temperature, powder-20 °C or lowerProtect from light and moisture
Storage temperature, reconstituted2-8 °CUse within days
Purity testingReversed-phase HPLCSeparates truncation products
Mass confirmationMass spectrometryDetects deamidation and oxidation
Common salt formsAcetate or trifluoroacetateAffects solubility and weighing

Handling, Storage, and Analytical Methods

Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.

The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.

Related pages on this site

Molecular Background and Immune Action

Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.

Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.

Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.

Notes from published material

Alba, a green-fluorescent rabbit, was created by a French laboratory commissioned by Eduardo Kac using GFP for purposes of art and social commentary. The US company Yorktown Technologies markets to aquarium shops green fluorescent zebrafish (GloFish) that were initially developed to detect pollution in waterways. NeonPets, a US-based company has marketed green fluorescent mice to the pet industry as NeonMice. Green fluorescent pigs, known as Noels, were bred by a group of researchers led by Wu Shinn-Chih at the Department of Animal Science and Technology at National Taiwan University. A Japanese-American Team created green-fluorescent cats as proof of concept to use them potentially as model organisms for diseases, particularly HIV. In 2009 a South Korean team from Seoul National University bred the first transgenic beagles with fibroblast cells from sea anemones. The dogs give off a red fluorescent light, and they are meant to allow scientists to study the genes that cause human diseases like narcolepsy and blindness.

According to the Romania's National Institute of Statistics (INS), Romania's total road network was estimated in 2015 at 86,080 kilometres (53,488 mi). The World Bank estimates the railway network at 22,298 kilometres (13,855 mi) of track, the fourth-largest railway network in Europe. Romania's rail transport experienced a dramatic decline after 1989 and was estimated at 99 million passenger journeys in 2004, but has experienced a recent (2013) revival due to infrastructure improvements and partial privatisation of lines, accounting for 45% of all passenger and freight movements in the country. Bucharest Metro, the only underground railway system, was opened in 1979 and measures 80.01 km (49.72 mi) with an average ridership in 2021 of 720,000 passengers during the workweek in the country. There are sixteen international commercial airports in service today. Over 12.8 million passengers flew through Bucharest's Henri Coandă International Airport in 2017. Romania is a net exporter of electrical energy and is 52nd worldwide in terms of consumption of electric energy. Around a third of the produced energy comes from renewable sources, mostly as hydroelectric power. It has one of the largest refining capacities in Eastern Europe, even though oil and natural gas production has been decreasing for more than a decade. With one of the largest reserves of crude oil and shale gas in Europe it is among the most energy-independent countries in the EU, and is looking to expand its nuclear power plant at Cernavodă further.

==== Eukaryotic algae ==== In nearly all species of eukaryotic algae (Chloromonas being one notable exception), upon induction of the CCM, ~95% of RuBisCO is densely packed into a single subcellular compartment: the pyrenoid. Carbon dioxide is concentrated in this compartment using a combination of CO2 pumps, bicarbonate pumps, and carbonic anhydrases. The pyrenoid is not a membrane-bound compartment but is found within the chloroplast, often surrounded by a starch sheath (which is not thought to serve a function in the CCM).

Sources: en.wikipedia.org

Further detail

Passing alpha particles through a very thin glass window and trapping them in a discharge tube allowed researchers to study the emission spectrum of the captured particles, and ultimately proved that alpha particles are helium nuclei. Other experiments showed beta radiation, resulting from decay and cathode rays, were high-speed electrons. Likewise, gamma radiation and X-rays were found to be high-energy electromagnetic radiation. The relationship between the types of decays also began to be examined: For example, gamma decay was almost always found to be associated with other types of decay, and occurred at about the same time, or afterwards. Gamma decay as a separate phenomenon, with its own half-life (now termed isomeric transition), was found in natural radioactivity to be a result of the gamma decay of excited metastable nuclear isomers, which were in turn created from other types of decay. Although alpha, beta, and gamma radiations were most commonly found, other types of emission were eventually discovered. Shortly after the discovery of the positron in cosmic ray products, it was realized that the same process that operates in classical beta decay can also produce positrons (positron emission), along with neutrinos (classical beta decay produces antineutrinos).

Ethylene oxide is one of the most important raw materials used in large-scale chemical production. Most ethylene oxide is used for synthesis of ethylene glycols, including diethylene glycol and triethylene glycol, that accounts for up to 75% of global consumption. Other important products include ethylene glycol ethers, ethanolamines, and ethoxylates. Among glycols, ethylene glycol is used as antifreeze, in the production of polyester and polyethylene terephthalate (PET – raw material for plastic bottles), liquid coolants, and solvents.

== Absorption, metabolism and excretion == When found in foods, most pantothenic acid is in the form of CoA or bound to acyl carrier protein (ACP). For the intestinal cells to absorb this vitamin, it must be converted into free pantothenic acid. Within the lumen of the intestine, CoA and ACP are hydrolyzed into 4'-phosphopantetheine. The 4'-phosphopantetheine is then dephosphorylated into pantetheine. Pantetheinase, an intestinal enzyme, then hydrolyzes pantetheine into free pantothenic acid. Free pantothenic acid is absorbed into intestinal cells via a saturable, sodium-dependent active transport system. At high levels of intake, when this mechanism is saturated, some pantothenic acid may also be additionally absorbed via passive diffusion. As a whole, when intake increases 10-fold, absorption rate decreases to 10%. Pantothenic acid is excreted in urine. This occurs after its release from CoA. Urinary amounts are on the order of 2.6 mg/day, but decreased to negligible amounts when subjects in multi-week experimental situations were fed diets devoid of the vitamin. Mutation of pantothenate kinase (the first enzyme in the pathway converting pantothenic acid to CoA) is the cause of pantothenate kinase associated neurodegeneration (PKAN), a rare neurodegenerative disease.

Since travellers exiting Hyder into Stewart, British Columbia, are subject to Canadian border controls, it is theoretically possible for someone to accidentally enter Hyder from Canada without their travel documents and then face difficulties, as both the U.S. and Canada would subject them to border controls that require travel documents. At the same time, however, the northern road connecting Hyder to the uninhabited mountain regions of British Columbia has neither American nor Canadian border controls, meaning that tourists from Canada proceeding northwards from Hyder are required to complete Canadian immigration formalities when they return to Stewart, despite never having cleared American immigration.

Sources: en.wikipedia.org

Frequently asked questions

Can the powder be stored at room temperature?

Dry lyophilized powder tolerates short ambient exposure during handling and shipping. Long-term room-temperature storage is not recommended because moisture uptake and slow degradation can occur over months. Storage at minus twenty degrees Celsius is the common practice for extended periods.

What does a certificate of analysis usually include?

Typical entries list appearance, identity by mass spectrometry, purity by chromatography, water or moisture content, and residual counter-ion. Some certificates also report microbial limits and endotoxin for materials intended for laboratory use. The reported methods and acceptance ranges vary between suppliers.

Why does the salt form matter?

The peptide is often supplied as an acetate or trifluoroacetate salt, and the counter-ion affects solubility, weight-per-mole calculations, and compatibility with cell assays. Trifluoroacetate can be undesirable in some biological experiments. Knowing the salt form is necessary for accurate concentration determination.

Is thymosin alpha-1 a naturally occurring hormone?

It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.

Network